{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:21:18Z","timestamp":1744172478324,"version":"3.40.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,8]]},"DOI":"10.7759\/cureus.81881","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:14:03Z","timestamp":1744114443000},"source":"Crossref","is-referenced-by-count":0,"title":["Exploring Surgical Oncology-Based Comparative and Systematic Analysis of the Diagnostic Potential of Various Novel Biomarkers in Head and Neck Squamous Cell Carcinoma"],"prefix":"10.7759","author":[{"given":"Mostafa Ahmed","family":"Abdellah Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Batool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aws Khaled","family":"Mohammad Rababah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeeha","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Mannan","family":"Jehangir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryum","family":"Sana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan Ul Haq","family":"Mzahri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/medsci11020042","article-title":"Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma","volume":"11","author":"Barsouk A","year":"2023","unstructured":"Barsouk A, Aluru JS, Rawla P, Saginala K, Barsouk A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med Sci (Basel). 2023, 11:42. 10.3390\/medsci11020042","journal-title":"Med Sci (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020338","article-title":"Recent advances and future directions in clinical management of head and neck squamous cell carcinoma","volume":"13","author":"Muzaffar J","year":"2021","unstructured":"Muzaffar J, Bari S, Kirtane K, Chung CH. Recent advances and future directions in clinical management of head and neck squamous cell carcinoma. Cancers (Basel). 2021, 13:338. 10.3390\/cancers13020338","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00827","article-title":"Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting","volume":"9","author":"Economopoulou P","year":"2019","unstructured":"Economopoulou P, de Bree R, Kotsantis I, Psyrri A. Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting. Front Oncol. 2019, 9:827. 10.3389\/fonc.2019.00827","journal-title":"Front Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1148\/rg.240037","article-title":"Molecular markers in the World Health Organization classification of head and neck tumors, fifth edition","volume":"44","author":"Agarwal A","year":"2024","unstructured":"Agarwal A, Bathla G, Bhatt A, et al.. Molecular markers in the World Health Organization classification of head and neck tumors, fifth edition. Radiographics. 2024, 44:e240037. 10.1148\/rg.240037","journal-title":"Radiographics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225514","article-title":"Insight into classification and risk stratification of head and neck squamous cell carcinoma in era of emerging biomarkers with focus on histopathologic parameters","volume":"14","author":"M\u00e4kitie AA","year":"2022","unstructured":"M\u00e4kitie AA, Agaimy A, Almangush A. Insight into classification and risk stratification of head and neck squamous cell carcinoma in era of emerging biomarkers with focus on histopathologic parameters. Cancers (Basel). 2022, 14:14. 10.3390\/cancers14225514","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122884","article-title":"The role of immune modulatory cytokines in the tumor microenvironments of head and neck squamous cell carcinomas","volume":"14","author":"Kondoh N","year":"2022","unstructured":"Kondoh N, Mizuno-Kamiya M. The role of immune modulatory cytokines in the tumor microenvironments of head and neck squamous cell carcinomas. Cancers (Basel). 2022, 14:84. 10.3390\/cancers14122884","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06580-w","article-title":"Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma","volume":"278","author":"Ding Z","year":"2021","unstructured":"Ding Z, Li H, Yu D. Development and validation of a hypoxia-related gene pair signature to predict overall survival in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2021, 278:3973-83. 10.1007\/s00405-020-06580-w","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/09553002.2022.2110301","article-title":"Biomarkers of radioresistance in head and neck squamous cell carcinomas","volume":"99","author":"Avril D","year":"2023","unstructured":"Avril D, Foy JP, Bouaoud J, Gr\u00e9goire V, Saintigny P. Biomarkers of radioresistance in head and neck squamous cell carcinomas. Int J Radiat Biol. 2023, 99:583-93. 10.1080\/09553002.2022.2110301","journal-title":"Int J Radiat Biol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29590","article-title":"Clinicopathological and prognostic significance of PD-1\/PD-L1 axis expression in patients with tongue squamous cell carcinoma","volume":"235","author":"Huang W","year":"2020","unstructured":"Huang W, Zhou X, Liao Q, et al.. Clinicopathological and prognostic significance of PD-1\/PD-L1 axis expression in patients with tongue squamous cell carcinoma. J Cell Physiol. 2020, 235:6942-53. 10.1002\/jcp.29590","journal-title":"J Cell Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28142","article-title":"Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma","volume":"130","author":"Sanada T","year":"2020","unstructured":"Sanada T, Islam A, Kaminota T, et al.. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma. Laryngoscope. 2020, 130:E327-34. 10.1002\/lary.28142","journal-title":"Laryngoscope"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00606-3","article-title":"Immunohistochemical study of PD-1\/PD-L1 axis expression in oral tongue squamous cell carcinomas: effect of neoadjuvant chemotherapy on local recurrence","volume":"26","author":"Naruse T","year":"2020","unstructured":"Naruse T, Yanamoto S, Okuyama K, et al.. Immunohistochemical study of PD-1\/PD-L1 axis expression in oral tongue squamous cell carcinomas: effect of neoadjuvant chemotherapy on local recurrence. Pathol Oncol Res. 2020, 26:735-42. 10.1007\/s12253-019-00606-3","journal-title":"Pathol Oncol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00700-6","article-title":"Expression of hTERT in oral submucous fibrosis and oral squamous cell carcinoma - an immunohistochemical analysis","volume":"26","author":"Lizbeth Raju K","year":"2020","unstructured":"Lizbeth Raju K, Haragannavar VC, Patil S, et al.. Expression of hTERT in oral submucous fibrosis and oral squamous cell carcinoma - an immunohistochemical analysis. Pathol Oncol Res. 2020, 26:1573-82. 10.1007\/s12253-019-00700-6","journal-title":"Pathol Oncol Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00732-y","article-title":"Focal adhesion kinase (FAK) overexpression and phosphorylation in oral squamous cell carcinoma and their clinicopathological significance","volume":"26","author":"Kato A","year":"2020","unstructured":"Kato A, Kato K, Miyazawa H, Kobayashi H, Noguchi N, Kawashiri S. Focal adhesion kinase (FAK) overexpression and phosphorylation in oral squamous cell carcinoma and their clinicopathological significance. Pathol Oncol Res. 2020, 26:1659-67. 10.1007\/s12253-019-00732-y","journal-title":"Pathol Oncol Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgz182","article-title":"Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas","volume":"41","author":"Elkashty OA","year":"2020","unstructured":"Elkashty OA, Abu Elghanam G, Su X, Liu Y, Chauvin PJ, Tran SD. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas. Carcinogenesis. 2020, 41:458-66. 10.1093\/carcin\/bgz182","journal-title":"Carcinogenesis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2020.824","article-title":"Outcomes and biomarkers of immune checkpoint inhibitor therapy in patients with refractory head and neck squamous cell carcinoma: KCSG HN18-12","volume":"53","author":"Lee YG","year":"2021","unstructured":"Lee YG, Chang H, Keam B, et al.. Outcomes and biomarkers of immune checkpoint inhibitor therapy in patients with refractory head and neck squamous cell carcinoma: KCSG HN18-12. Cancer Res Treat. 2021, 53:671-7. 10.4143\/crt.2020.824","journal-title":"Cancer Res Treat"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081658","article-title":"Potential non-invasive biomarkers for early diagnosis of oral squamous cell carcinoma","volume":"10","author":"Dikova V","year":"2021","unstructured":"Dikova V, Jantus-Lewintre E, Bagan J. Potential non-invasive biomarkers for early diagnosis of oral squamous cell carcinoma. J Clin Med. 2021, 10:58. 10.3390\/jcm10081658","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04598-9","article-title":"Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy-results from a prospective trial","volume":"47","author":"Nicolay NH","year":"2020","unstructured":"Nicolay NH, Wiedenmann N, Mix M, Weber WA, Werner M, Grosu AL, Kayser G. Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy-results from a prospective trial. Eur J Nucl Med Mol Imaging. 2020, 47:1046-55. 10.1007\/s00259-019-04598-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-019-03129-y","article-title":"Guanylate-binding protein 6 is a novel biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma","volume":"24","author":"Liu PF","year":"2020","unstructured":"Liu PF, Chen HC, Shu CW, et al.. Guanylate-binding protein 6 is a novel biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma. Clin Oral Investig. 2020, 24:2673-82. 10.1007\/s00784-019-03129-y","journal-title":"Clin Oral Investig"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28408-3","article-title":"Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)","volume":"13","author":"Xu J","year":"2022","unstructured":"Xu J, Li Y, Fan Q, et al.. Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2). Nat Commun. 2022, 13:857. 10.1038\/s41467-022-28408-3","journal-title":"Nat Commun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0145561319876910","article-title":"Prognostic analysis of preoperative inflammatory biomarkers in patients with laryngeal squamous cell carcinoma","volume":"99","author":"Xun Y","year":"2020","unstructured":"Xun Y, Wang M, Sun H, Shi S, Guan B, Yu C. Prognostic analysis of preoperative inflammatory biomarkers in patients with laryngeal squamous cell carcinoma. Ear Nose Throat J. 2020, 99:371-8. 10.1177\/0145561319876910","journal-title":"Ear Nose Throat J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010240","article-title":"Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma","volume":"22","author":"Kitamura N","year":"2020","unstructured":"Kitamura N, Sento S, Yoshizawa Y, Sasabe E, Kudo Y, Yamamoto T. Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma. Int J Mol Sci. 2020, 22:240. 10.3390\/ijms22010240","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.988416","article-title":"Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer","volume":"13","author":"Jiang S","year":"2022","unstructured":"Jiang S, Li X, Huang L, Xu Z, Lin J. Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer. Front Immunol. 2022, 13:16. 10.3389\/fimmu.2022.988416","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06587-9","article-title":"Hypoxia-induced miR-5100 promotes exosome-mediated activation of cancer-associated fibroblasts and metastasis of head and neck squamous cell carcinoma","volume":"15","author":"Duan Y","year":"2024","unstructured":"Duan Y, Zhou M, Ye B, et al.. Hypoxia-induced miR-5100 promotes exosome-mediated activation of cancer-associated fibroblasts and metastasis of head and neck squamous cell carcinoma. Cell Death Dis. 2024, 15:215. 10.1038\/s41419-024-06587-9","journal-title":"Cell Death Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdsr.2023.10.003","article-title":"Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head\/neck squamous cell carcinoma (HNSCC): a systematic review and network meta-analysis","volume":"60","author":"Khijmatgar S","year":"2024","unstructured":"Khijmatgar S, Yong J, R\u00fcbsamen N, et al.. Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head\/neck squamous cell carcinoma (HNSCC): a systematic review and network meta-analysis. Jpn Dent Sci Rev. 2024, 60:32-9. 10.1016\/j.jdsr.2023.10.003","journal-title":"Jpn Dent Sci Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03316-0","article-title":"Targeting HIF-1\u03b1\/NOTCH1 pathway eliminates CD44(+) cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma","volume":"44","author":"Byun JY","year":"2025","unstructured":"Byun JY, Huang K, Lee JS, et al.. Targeting HIF-1\u03b1\/NOTCH1 pathway eliminates CD44(+) cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma. Oncogene. 2025, 44:782. 10.1038\/s41388-025-03316-0","journal-title":"Oncogene"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105348","article-title":"Single-cell profiling of tumor-infiltrating TCF1\/TCF7(+) T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures\/organs and a superior prognosis in oral cancer","volume":"119","author":"Peng Y","year":"2021","unstructured":"Peng Y, Xiao L, Rong H, et al.. Single-cell profiling of tumor-infiltrating TCF1\/TCF7(+) T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures\/organs and a superior prognosis in oral cancer. Oral Oncol. 2021, 119:105348. 10.1016\/j.oraloncology.2021.105348","journal-title":"Oral Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25872","article-title":"Hallmarks of cancer: tumor budding as a sign of invasion and metastasis in head and neck cancer","volume":"41","author":"M\u00e4kitie AA","year":"2019","unstructured":"M\u00e4kitie AA, Almangush A, Rodrigo JP, Ferlito A, Leivo I. Hallmarks of cancer: tumor budding as a sign of invasion and metastasis in head and neck cancer. Head Neck. 2019, 41:3712-8. 10.1002\/hed.25872","journal-title":"Head Neck"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2021.2191","article-title":"Neoadjuvant PD-1\/PD-L1 inhibitors for resectable head and neck cancer: a systematic review and meta-analysis","volume":"147","author":"Masarwy R","year":"2021","unstructured":"Masarwy R, Kampel L, Horowitz G, Gutfeld O, Muhanna N. Neoadjuvant PD-1\/PD-L1 inhibitors for resectable head and neck cancer: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2021, 147:871-8. 10.1001\/jamaoto.2021.2191","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-022-07571-9","article-title":"PD-1\/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma","volume":"280","author":"Mo DC","year":"2023","unstructured":"Mo DC, Huang JF, Luo PH, Chen L, Zou B, Wang HL. PD-1\/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2023, 280:1-9. 10.1007\/s00405-022-07571-9","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00418-5","article-title":"Head and neck squamous cell carcinoma","volume":"9","author":"Johnson DE","year":"2023","unstructured":"Johnson DE, Burtness B, Leemans CR, Lui VW, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2023, 9:4. 10.1038\/s41572-023-00418-5","journal-title":"Nat Rev Dis Primers"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/355299-exploring-surgical-oncology-based-comparative-and-systematic-analysis-of-the-diagnostic-potential-of-various-novel-biomarkers-in-head-and-neck-squamous-cell-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:14:03Z","timestamp":1744114443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/355299-exploring-surgical-oncology-based-comparative-and-systematic-analysis-of-the-diagnostic-potential-of-various-novel-biomarkers-in-head-and-neck-squamous-cell-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.81881","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,8]]}}}